Tumour cell retention of rucaparib, sustained PARP inhibition and efficacy of weekly as well as daily schedules
作者： J Murray , H Thomas , P Berry , S Kyle , M Patterson
DOI: 10.1038/BJC.2014.91
关键词:
摘要: Tumour cell retention of rucaparib, sustained PARP inhibition and efficacy weekly as well daily schedules
nature.com
sci-hub.se 参考文章(22)
KJ Dedes, P Wilkerson, D Wetterskog, MB Lambros, R Natrajan, D Tan, CJ Lord, SB Kaye, A Ashworth, JS Reis-Filho, Preclinical evaluation of the PARP-inhibitor olaparib for the treatment of ovarian clear cell cancer Geburtshilfe Und Frauenheilkunde. ,vol. 71, ,(2011) , 10.1055/S-0031-1286501
Masahiko S. Satoh, Tomas Lindahl, Role of poly(ADP-ribose) formation in DNA repair Nature. ,vol. 356, pp. 356- 358 ,(1992) , 10.1038/356356A0
Hannah Farmer, Nuala McCabe, Christopher J. Lord, Andrew N. J. Tutt, Damian A. Johnson, Tobias B. Richardson, Manuela Santarosa, Krystyna J. Dillon, Ian Hickson, Charlotte Knights, Niall M. B. Martin, Stephen P. Jackson, Graeme C. M. Smith, Alan Ashworth, Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy Nature. ,vol. 434, pp. 917- 921 ,(2005) , 10.1038/NATURE03445
John F. Deeken, Wolfgang Löscher, The blood-brain barrier and cancer: transporters, treatment, and Trojan horses. Clinical Cancer Research. ,vol. 13, pp. 1663- 1674 ,(2007) , 10.1158/1078-0432.CCR-06-2854
Ruth Plummer, Christopher Jones, Mark Middleton, Richard Wilson, Jeffrey Evans, Anna Olsen, Nicola Curtin, Alan Boddy, Peter McHugh, David Newell, Adrian Harris, Patrick Johnson, Heidi Steinfeldt, Raz Dewji, Diane Wang, Lesley Robson, Hilary Calvert, Phase I Study of the Poly(ADP-Ribose) Polymerase Inhibitor, AG014699, in Combination with Temozolomide in Patients with Advanced Solid Tumors Clinical Cancer Research. ,vol. 14, pp. 7917- 7923 ,(2008) , 10.1158/1078-0432.CCR-08-1223
Helen E. Bryant, Niklas Schultz, Huw D. Thomas, Kayan M. Parker, Dan Flower, Elena Lopez, Suzanne Kyle, Mark Meuth, Nicola J. Curtin, Thomas Helleday, Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase Nature. ,vol. 434, pp. 913- 917 ,(2005) , 10.1038/NATURE03443
R A Daniel, A L Rozanska, E A Mulligan, Y Drew, H D Thomas, D J Castelbuono, Z Hostomsky, E R Plummer, D A Tweddle, A V Boddy, S C Clifford, N J Curtin, Central nervous system penetration and enhancement of temozolomide activity in childhood medulloblastoma models by poly(ADP-ribose) polymerase inhibitor AG-014699 British Journal of Cancer. ,vol. 103, pp. 1588- 1596 ,(2010) , 10.1038/SJ.BJC.6605946
Mike De Vos, Valérie Schreiber, Françoise Dantzer, The diverse roles and clinical relevance of PARPs in DNA damage repair: current state of the art. Biochemical Pharmacology. ,vol. 84, pp. 137- 146 ,(2012) , 10.1016/J.BCP.2012.03.018
Andrey Nikiforov, Christian Dölle, Marc Niere, Mathias Ziegler, Pathways and Subcellular Compartmentation of NAD Biosynthesis in Human Cells FROM ENTRY OF EXTRACELLULAR PRECURSORS TO MITOCHONDRIAL NAD GENERATION Journal of Biological Chemistry. ,vol. 286, pp. 21767- 21778 ,(2011) , 10.1074/JBC.M110.213298
Elisabet Wahlberg, Tobias Karlberg, Ekaterina Kouznetsova, Natalia Markova, Antonio Macchiarulo, Ann-Gerd Thorsell, Ewa Pol, Åsa Frostell, Torun Ekblad, Delal Öncü, Björn Kull, Graeme Michael Robertson, Roberto Pellicciari, Herwig Schüler, Johan Weigelt, Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors Nature Biotechnology. ,vol. 30, pp. 283- 288 ,(2012) , 10.1038/NBT.2121